Antanas Gulbinas

8PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 27, 2026
Circulating miR-21 and miR-181a as Biomarkers for Predicting Postoperative Complications Following Colorectal Cancer Resection: A Longitudinal Observational Study.

Kornelija Rauduvytė, Marius Kryžauskas, Domas Drazdauskas

|Jul 13, 2024
Preoperative Immune Cell Dysregulation Accompanies Ovarian Cancer Patients into the Postoperative Period.

Jonas Ulevicius, Aldona Jasukaitiene, Arenida Bartkeviciene

|Jan 23, 2024
Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo.

Justas Žilinskas, Darius Stukas, Aldona Jasukaitienė

|Sep 28, 2023
Association between AHR Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells.

Arenida Bartkeviciene, Aldona Jasukaitiene, Inga Zievyte

|Sep 09, 2023
Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway.

Darius Stukas, Aldona Jasukaitiene, Arenida Bartkeviciene

|May 27, 2023
Editorial for the Special Issue "Acute and Chronic Pancreatitis, Pancreatic Malignancies".

Antanas Gulbinas, Povilas Ignatavicius, Zilvinas Dambrauskas

Pageof 2

Frequent Collaborators

6 joint publications

Zilvinas Dambrauskas

3 joint publications

Darius Stukas

3 joint publications

Aldona Jasukaitienė

2 joint publications

Kristaps Jaudzems